Orenitram (treprostinil) Extended Release Tablets 

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)   January 2016 ADVERSE REACTIONS Clinical Trials Experience …The safety of Orenitram was also evaluated in an open-label...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts